Published on
Dec 13, 2024
Multimodal machine learning model effective at predicting response to CDK4/6 inhibitors in HR-positive, HER2-negative ...
SAN ANTONIO – A machine learning (ML) model incorporating both clinical and genomic factors outperformed models based solely on either clinical or genomic data in predicting which patients with hormone receptor (HR)-positive, HER2-negative metastatic …
Source:
EurekAlert!
-
Neutral
